BioTech News Headlines - Yahoo! News

http://news.yahoo.com/biotech/ Get the latest Biotech news headlines from Yahoo! News. Find breaking Biotech news, including analysis and opinion on top Biotech stories, photos and more.en-USCopyright (c) 2013 Yahoo! Inc. All rights reservedMon, 15 Jul 2013 12:00:50 -04005http://news.yahoo.com/biotech/ http://l.yimg.com/a/i/us/nws/th/main_142c.gifBy Ben Hirschler LONDON (Reuters) - Scientists have unraveled how a gene long associated with obesity makes people fat by triggering increased hunger, opening up potential new ways to fight a growing global health problem. A common variation in the FTO gene affects one in six of the population, making them 70 percent more likely to become obese - but until now experts did not know why. ...http://news.yahoo.com/scientists-obesity-gene-makes-people-fat-160050035.htmlMon, 15 Jul 2013 12:00:50 -0400Reutersscientists-obesity-gene-makes-people-fat-160050035By Esha Dey and Pallavi Ail (Reuters) - A radical new treatment for genetic disorders has catapulted Alnylam Pharmaceuticals Inc into the crosshairs of investors seeking the next breakthrough name in biotechnology. The challenge for the Cambridge, Massachusetts-based company now is to prove that its 'gene silencing' technology can make the leap from the laboratory to the doctor's office and eclipse an alternative therapy already in use. Investors, for now, are betting that it will. A steady drip of positive trial data has helped to triple Alnylam's market value to more than $2. ...http://news.yahoo.com/alnylam-bets-gene-silencing-woo-biotech-investors-144723013.htmlFri, 12 Jul 2013 10:47:23 -0400Reutersalnylam-bets-gene-silencing-woo-biotech-investors-144723013(Reuters) - Alnylam Pharmaceuticals Inc said an early-stage trial of its gene-based therapy showed the drug was effective in suppressing a protein that causes a rare organ-damaging hereditary disorder. Alnylam shares rose 14 percent to $42.80 in premarket trade. The study was testing a subcutaneously administered version of the drug, ALN-TTR, to treat genetic disorder amyloidosis, which is caused by deposits of protein in tissues and organs. ...http://news.yahoo.com/alnylam-drug-found-effective-treating-rare-genetic-disease-132403151.htmlThu, 11 Jul 2013 09:24:03 -0400Reutersalnylam-drug-found-effective-treating-rare-genetic-disease-132403151Myriad Genetics Inc. is suing two privately-held competitors to stop it from selling a genetic test that competes with Myriad's BRACAnalysis breast and ovarian cancer test. Myriad says Ambry Genetics Corp. ...http://news.yahoo.com/myriad-sues-competitor-overs-cancer-223108993.htmlWed, 10 Jul 2013 18:31:08 -0400Associated Pressmyriad-sues-competitor-overs-cancer-223108993Myriad Genetics Inc. is suing a privately-held competitor to stop it from selling a genetic test that competes with Myriad's BRACAnalysis breast and ovarian cancer test. Myriad says Ambry Genetics Corp. ...http://news.yahoo.com/myriad-sues-competitor-over-cancer-205137780.htmlWed, 10 Jul 2013 16:51:37 -0400Associated Pressmyriad-sues-competitor-over-cancer-205137780<p><a href="http://news.yahoo.com/first-child-receive-windpipe-grown-own-stem-cells-160616412.html"><img src="http://l1.yimg.com/bt/api/res/1.2/GFPuq_Gz_TFcEb7GGPwOlg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-07-09T163904Z_1_CBRE9681A9700_RTROPTP_2_USA-ILLINOIS-STEMCELL.JPG" width="130" height="86" alt="Hannah Warren is pictured at the Children&#039;s Hospital of Illinois, in Peoria, Illinois" align="left" title="Hannah Warren is pictured at the Children&#039;s Hospital of Illinois, in Peoria, Illinois" border="0" /></a>By Chris Francescani (Reuters) - Two-year-old Hannah Warren, the first child to receive a windpipe grown from her own stem cells, has died three months after a rare operation, the Children&#039;s Hospital of Illinois in Peoria said. The child was diagnosed with an uncommon congenital abnormality known as tracheal agenesis, which means her windpipe failed to develop. She could not talk, eat or swallow on her own, according to a website by her parents, Darryl and Young-Mi Warren. ...</p><br clear="all"/>http://news.yahoo.com/first-child-receive-windpipe-grown-own-stem-cells-160616412.htmlTue, 09 Jul 2013 13:10:48 -0400Reutersfirst-child-receive-windpipe-grown-own-stem-cells-160616412<p><a href="http://news.yahoo.com/first-child-receive-windpipe-grown-own-stem-cells-160616412.html"><img src="http://l1.yimg.com/bt/api/res/1.2/GFPuq_Gz_TFcEb7GGPwOlg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-07-09T163904Z_1_CBRE9681A9700_RTROPTP_2_USA-ILLINOIS-STEMCELL.JPG" width="130" height="86" alt="Hannah Warren is pictured at the Children&#039;s Hospital of Illinois, in Peoria, Illinois" align="left" title="Hannah Warren is pictured at the Children&#039;s Hospital of Illinois, in Peoria, Illinois" border="0" /></a>By Chris Francescani (Reuters) - Two-year-old Hannah Warren, the first child to receive a windpipe grown from her own stem cells, has died three months after a rare operation, the Children&#039;s Hospital of Illinois in Peoria said. The child was diagnosed with an uncommon congenital abnormality known as tracheal agenesis, which means her windpipe failed to develop. She could not talk, eat or swallow on her own, according to a website by her parents, Darryl and Young-Mi Warren. ...</p><br clear="all"/><p><a href="http://news.yahoo.com/2-stem-cell-patients-stop-hiv-drugs-no-112746486.html"><img src="http://l3.yimg.com/bt/api/res/1.2/d8LencqPZ80U5zMMq9YShw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/ap_webfeeds/427a1fd937878116360f6a706700835f.jpg" width="130" height="86" alt="Timothy Henrich of the Harvard-affiliated Brigham and Women&#039;s Hospital in Boston speaks at the International AIDS Society Conference 2013 in Kuala Lumpur, Malaysia, Wednesday, July 3, 2013. Two HIV-positive patients in the United States who underwent bone marrow transplants for cancer have stopped anti-retroviral therapy and still show no detectable sign of the HIV virus, researchers said Wednesday. (AP Photo/Lai Seng Sin)" align="left" title="Timothy Henrich of the Harvard-affiliated Brigham and Women&#039;s Hospital in Boston speaks at the International AIDS Society Conference 2013 in Kuala Lumpur, Malaysia, Wednesday, July 3, 2013. Two HIV-positive patients in the United States who underwent bone marrow transplants for cancer have stopped anti-retroviral therapy and still show no detectable sign of the HIV virus, researchers said Wednesday. (AP Photo/Lai Seng Sin)" border="0" /></a>KUALA LUMPUR, Malaysia (AP) ? Two HIV-positive patients in the United States who underwent bone marrow transplants for cancer have stopped anti-retroviral therapy and still show no detectable sign of the HIV virus, researchers said Wednesday.</p><br clear="all"/>http://news.yahoo.com/2-stem-cell-patients-stop-hiv-drugs-no-112746486.htmlWed, 03 Jul 2013 07:36:09 -0400Associated Press2-stem-cell-patients-stop-hiv-drugs-no-112746486<p><a href="http://news.yahoo.com/2-stem-cell-patients-stop-hiv-drugs-no-112746486.html"><img src="http://l3.yimg.com/bt/api/res/1.2/d8LencqPZ80U5zMMq9YShw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/ap_webfeeds/427a1fd937878116360f6a706700835f.jpg" width="130" height="86" alt="Timothy Henrich of the Harvard-affiliated Brigham and Women&#039;s Hospital in Boston speaks at the International AIDS Society Conference 2013 in Kuala Lumpur, Malaysia, Wednesday, July 3, 2013. Two HIV-positive patients in the United States who underwent bone marrow transplants for cancer have stopped anti-retroviral therapy and still show no detectable sign of the HIV virus, researchers said Wednesday. (AP Photo/Lai Seng Sin)" align="left" title="Timothy Henrich of the Harvard-affiliated Brigham and Women&#039;s Hospital in Boston speaks at the International AIDS Society Conference 2013 in Kuala Lumpur, Malaysia, Wednesday, July 3, 2013. Two HIV-positive patients in the United States who underwent bone marrow transplants for cancer have stopped anti-retroviral therapy and still show no detectable sign of the HIV virus, researchers said Wednesday. (AP Photo/Lai Seng Sin)" border="0" /></a>KUALA LUMPUR, Malaysia (AP) ? Two HIV-positive patients in the United States who underwent bone marrow transplants for cancer have stopped anti-retroviral therapy and still show no detectable sign of the HIV virus, researchers said Wednesday.</p><br clear="all"/>By Kate Kelland LONDON (Reuters) - Scientists have for the first time created a functional human liver from stem cells derived from skin and blood and say their success points to a future where much-needed livers and other transplant organs could be made in a laboratory. While it may take another 10 years before lab-grown livers could be used to treat patients, the Japanese scientists say they now have important proof of concept that paves the way for more ambitious organ-growing experiments. ...http://news.yahoo.com/scientists-create-human-liver-stem-cells-033554646.htmlWed, 03 Jul 2013 23:35:54 -0400Reutersscientists-create-human-liver-stem-cells-033554646By Ben Hirschler LONDON (Reuters) - Two men with HIV have been off AIDS drugs for several months after receiving stem-cell transplants for cancer that appear to have cleared the virus from their bodies, researchers reported on Wednesday. Both patients, who were treated in Boston and had been on long-term drug therapy to control their HIV, received stem-cell transplants after developing lymphoma, a type of blood cancer. ...http://news.yahoo.com/stem-cell-therapy-wipes-hiv-two-patients-115302059.htmlWed, 03 Jul 2013 07:53:02 -0400Reutersstem-cell-therapy-wipes-hiv-two-patients-115302059<p><a href="http://news.yahoo.com/world-food-prize-goes-3-170632624.html"><img src="http://l1.yimg.com/bt/api/res/1.2/KhghTjhCNUmZ9Q_xzFkPtA--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://globalfinance.zenfs.com/images/US_AHTTP_AP_FINANCIALTIMES/28f0b2d288923914350f6a706700cc56_original.jpg" width="130" height="86" alt="World Food Prize goes to 3 biotech scientists" align="left" title="World Food Prize goes to 3 biotech scientists" border="0" /></a>The World Food Prize Foundation on Wednesday took the bold step of awarding this year&#039;s prize to three pioneers of plant biotechnology whose work brought the world genetically modified crops. The private ...</p><br clear="all"/>http://news.yahoo.com/world-food-prize-goes-3-170632624.htmlWed, 19 Jun 2013 14:39:54 -0400Associated Pressworld-food-prize-goes-3-170632624<p><a href="http://news.yahoo.com/world-food-prize-goes-3-170632624.html"><img src="http://l1.yimg.com/bt/api/res/1.2/KhghTjhCNUmZ9Q_xzFkPtA--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://globalfinance.zenfs.com/images/US_AHTTP_AP_FINANCIALTIMES/28f0b2d288923914350f6a706700cc56_original.jpg" width="130" height="86" alt="World Food Prize goes to 3 biotech scientists" align="left" title="World Food Prize goes to 3 biotech scientists" border="0" /></a>The World Food Prize Foundation on Wednesday took the bold step of awarding this year&#039;s prize to three pioneers of plant biotechnology whose work brought the world genetically modified crops. The private ...</p><br clear="all"/>NEW YORK (AP) ? Shares of gene therapy developer Bluebird Bio Inc. surged in their trading debut.http://news.yahoo.com/bluebird-bio-shares-rocket-higher-trading-debut-152519370.htmlWed, 19 Jun 2013 19:12:45 -0400Associated Pressbluebird-bio-shares-rocket-higher-trading-debut-152519370<p><a href="http://news.yahoo.com/court-ruling-may-open-breast-cancer-gene-tests-180022078.html"><img src="http://l2.yimg.com/bt/api/res/1.2/94lCu8UF8oTJAV2lEoTwLQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/ap_webfeeds/d1f04896cf25a913340f6a706700a121.jpg" width="130" height="86" alt="FILE - A technician loads patient samples into a machine for testing at Myriad Genetics Friday, May 31, 2002, in Salt Lake City. DNA samples are moved from one tray to another by the eight-needle apparatus at left. The Supreme Court ruled Thursday, June 13, 2013 that Myriad Genetics Inc. cannot patent the BRCA genes, which are tested to check a woman?s risk for breast and ovarian cancer. Mutations in these genes are what led Angelina Jolie to have both her breasts removed because she had such a high cancer risk. Some experts think the court ruling may lead to lower cost testing because there could be more competition. (AP Photo/Douglas C. Pizac)" align="left" title="FILE - A technician loads patient samples into a machine for testing at Myriad Genetics Friday, May 31, 2002, in Salt Lake City. DNA samples are moved from one tray to another by the eight-needle apparatus at left. The Supreme Court ruled Thursday, June 13, 2013 that Myriad Genetics Inc. cannot patent the BRCA genes, which are tested to check a woman?s risk for breast and ovarian cancer. Mutations in these genes are what led Angelina Jolie to have both her breasts removed because she had such a high cancer risk. Some experts think the court ruling may lead to lower cost testing because there could be more competition. (AP Photo/Douglas C. Pizac)" border="0" /></a>A ruling by the Supreme Court that human genes can&#039;t be patented is expected to increase access and drop the cost for tests for gene mutations that greatly raise the risk of developing breast or ovarian cancer.</p><br clear="all"/>http://news.yahoo.com/court-ruling-may-open-breast-cancer-gene-tests-180022078.htmlThu, 13 Jun 2013 19:35:35 -0400Associated Presscourt-ruling-may-open-breast-cancer-gene-tests-180022078<p><a href="http://news.yahoo.com/court-ruling-may-open-breast-cancer-gene-tests-180022078.html"><img src="http://l2.yimg.com/bt/api/res/1.2/94lCu8UF8oTJAV2lEoTwLQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/ap_webfeeds/d1f04896cf25a913340f6a706700a121.jpg" width="130" height="86" alt="FILE - A technician loads patient samples into a machine for testing at Myriad Genetics Friday, May 31, 2002, in Salt Lake City. DNA samples are moved from one tray to another by the eight-needle apparatus at left. The Supreme Court ruled Thursday, June 13, 2013 that Myriad Genetics Inc. cannot patent the BRCA genes, which are tested to check a woman?s risk for breast and ovarian cancer. Mutations in these genes are what led Angelina Jolie to have both her breasts removed because she had such a high cancer risk. Some experts think the court ruling may lead to lower cost testing because there could be more competition. (AP Photo/Douglas C. Pizac)" align="left" title="FILE - A technician loads patient samples into a machine for testing at Myriad Genetics Friday, May 31, 2002, in Salt Lake City. DNA samples are moved from one tray to another by the eight-needle apparatus at left. The Supreme Court ruled Thursday, June 13, 2013 that Myriad Genetics Inc. cannot patent the BRCA genes, which are tested to check a woman?s risk for breast and ovarian cancer. Mutations in these genes are what led Angelina Jolie to have both her breasts removed because she had such a high cancer risk. Some experts think the court ruling may lead to lower cost testing because there could be more competition. (AP Photo/Douglas C. Pizac)" border="0" /></a>A ruling by the Supreme Court that human genes can&#039;t be patented is expected to increase access and drop the cost for tests for gene mutations that greatly raise the risk of developing breast or ovarian cancer.</p><br clear="all"/>By Sharon Begley NEW YORK (Reuters) - The U.S. Supreme Court decision on Thursday to uphold patent protections for genetic material that has been changed in the laboratory but invalidate patents for purely natural DNA may seem like a partial setback for the biotech industry, but experts said it isn't: the industry has already moved on. ...http://news.yahoo.com/top-court-invalidates-gene-patents-biotech-moved-230732022.htmlThu, 13 Jun 2013 19:07:32 -0400Reuterstop-court-invalidates-gene-patents-biotech-moved-230732022ROLLERCOASTER REACTION: Diagnostic test maker Myriad Genetics saw its shares jump 10 percent, then plunge. The volatility was triggered by the Supreme Court's mixed ruling on the validity of patents for ...http://news.yahoo.com/news-summary-myriad-stock-volatile-224626640.htmlThu, 13 Jun 2013 18:46:26 -0400Associated Pressnews-summary-myriad-stock-volatile-224626640Shares of diagnostic test maker Myriad Genetics Inc. surged Thursday after the Supreme Court handed the company a partial victory in a battle over validity of Myriad patents underlying its lucrative test ...http://news.yahoo.com/high-court-ruling-gene-patents-155411757.htmlThu, 13 Jun 2013 15:08:11 -0400Associated Presshigh-court-ruling-gene-patents-155411757<p><a href="http://news.yahoo.com/analysis-biotech-wheat-furor-shows-gm-food-safety-210446592.html"><img src="http://l3.yimg.com/bt/api/res/1.2/yc0IrkFnfD0n5h_2z4NwZg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-06-10T213442Z_1_CBRE9591NXY00_RTROPTP_2_US-WHEAT-KOREA.JPG" width="130" height="86" alt="An examiner demonstrates analyzing a genetically modified wheat sample, at the Ministry of Food and Drug Safety in Seoul" align="left" title="An examiner demonstrates analyzing a genetically modified wheat sample, at the Ministry of Food and Drug Safety in Seoul" border="0" /></a>By Carey Gillam (Reuters) - The refusal of some foreign buyers to purchase U.S. wheat after an unapproved genetically modified strain was discovered growing in a farm field in Oregon is the latest demonstration that the issue of biotech food safety is far from settled. Japan and South Korea canceled purchases of U.S. wheat after the discovery of the experimental wheat developed by Monsanto Co. The furor erupted just days after a May 25 protest in cities around the world targeting Monsanto, the leading developer of crops with transgenic DNA. At the crux of the concerns is the question of ...</p><br clear="all"/>http://news.yahoo.com/analysis-biotech-wheat-furor-shows-gm-food-safety-210446592.htmlMon, 10 Jun 2013 17:12:14 -0400Reutersanalysis-biotech-wheat-furor-shows-gm-food-safety-210446592<p><a href="http://news.yahoo.com/analysis-biotech-wheat-furor-shows-gm-food-safety-210446592.html"><img src="http://l3.yimg.com/bt/api/res/1.2/yc0IrkFnfD0n5h_2z4NwZg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-06-10T213442Z_1_CBRE9591NXY00_RTROPTP_2_US-WHEAT-KOREA.JPG" width="130" height="86" alt="An examiner demonstrates analyzing a genetically modified wheat sample, at the Ministry of Food and Drug Safety in Seoul" align="left" title="An examiner demonstrates analyzing a genetically modified wheat sample, at the Ministry of Food and Drug Safety in Seoul" border="0" /></a>By Carey Gillam (Reuters) - The refusal of some foreign buyers to purchase U.S. wheat after an unapproved genetically modified strain was discovered growing in a farm field in Oregon is the latest demonstration that the issue of biotech food safety is far from settled. Japan and South Korea canceled purchases of U.S. wheat after the discovery of the experimental wheat developed by Monsanto Co. The furor erupted just days after a May 25 protest in cities around the world targeting Monsanto, the leading developer of crops with transgenic DNA. At the crux of the concerns is the question of ...</p><br clear="all"/><p><a href="http://news.yahoo.com/gene-flaws-common-blacks-breast-cancer-121520504.html"><img src="http://l1.yimg.com/bt/api/res/1.2/r1syDASV2Hdpc.Sg7s7keA--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/ap_webfeeds/c52bff20992bb412330f6a7067002ef9.jpg" width="130" height="86" alt="In this May 31, 2013 photo, breast cancer survivor Alicia Cook holds photos of family members who have also been afflicted by breast cancer, outside her home in Chicago. New research shows genetic breast cancer is more common in black women than previously thought. (AP Photo/M. Spencer Green)" align="left" title="In this May 31, 2013 photo, breast cancer survivor Alicia Cook holds photos of family members who have also been afflicted by breast cancer, outside her home in Chicago. New research shows genetic breast cancer is more common in black women than previously thought. (AP Photo/M. Spencer Green)" border="0" /></a>CHICAGO (AP) ? Gene flaws that raise the risk of breast cancer are surprisingly common in black women with the disease, according to the first comprehensive testing in this racial group. The study found that one-fifth of these women have BRCA mutations, a problem usually associated with women of Eastern European Jewish descent but recently highlighted by the plight of Angelina Jolie.</p><br clear="all"/>http://news.yahoo.com/gene-flaws-common-blacks-breast-cancer-121520504.htmlMon, 03 Jun 2013 08:47:09 -0400Associated Pressgene-flaws-common-blacks-breast-cancer-121520504<p><a href="http://news.yahoo.com/gene-flaws-common-blacks-breast-cancer-121520504.html"><img src="http://l1.yimg.com/bt/api/res/1.2/r1syDASV2Hdpc.Sg7s7keA--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/ap_webfeeds/c52bff20992bb412330f6a7067002ef9.jpg" width="130" height="86" alt="In this May 31, 2013 photo, breast cancer survivor Alicia Cook holds photos of family members who have also been afflicted by breast cancer, outside her home in Chicago. New research shows genetic breast cancer is more common in black women than previously thought. (AP Photo/M. Spencer Green)" align="left" title="In this May 31, 2013 photo, breast cancer survivor Alicia Cook holds photos of family members who have also been afflicted by breast cancer, outside her home in Chicago. New research shows genetic breast cancer is more common in black women than previously thought. (AP Photo/M. Spencer Green)" border="0" /></a>CHICAGO (AP) ? Gene flaws that raise the risk of breast cancer are surprisingly common in black women with the disease, according to the first comprehensive testing in this racial group. The study found that one-fifth of these women have BRCA mutations, a problem usually associated with women of Eastern European Jewish descent but recently highlighted by the plight of Angelina Jolie.</p><br clear="all"/><p><a href="http://news.yahoo.com/advice-black-women-breast-cancer-gene-risk-200010535.html"><img src="http://l3.yimg.com/bt/api/res/1.2/IQXuyMvaKWQAC.5ySpGJZQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3B4b2ZmPTUwO3B5b2ZmPTA7cT04NTt3PTEzMA--/http://media.zenfs.com/en_us/News/ap_webfeeds/f5549e7f992eb412330f6a7067008a0f.jpg" width="130" height="86" alt="In this May 31, 2013, photo, breast cancer survivor Alicia Cook holds a letter from the University of Chicago informing her that test results showed she had the BRCA genetic defect linked to breast cancer, outside her home in Chicago. New research shows genetic breast cancer is more common in black women than previously thought. (AP Photo/M. Spencer Green)" align="left" title="In this May 31, 2013, photo, breast cancer survivor Alicia Cook holds a letter from the University of Chicago informing her that test results showed she had the BRCA genetic defect linked to breast cancer, outside her home in Chicago. New research shows genetic breast cancer is more common in black women than previously thought. (AP Photo/M. Spencer Green)" border="0" /></a>CHICAGO (AP) ? New research suggests that bad genes may be responsible for more breast cancer cases in black women than has been previously known. About 1 in 5 African-American women with the disease have an inherited mutation that drastically raises their risk for breast and ovarian cancer, according to a study released Monday.</p><br clear="all"/>http://news.yahoo.com/advice-black-women-breast-cancer-gene-risk-200010535.htmlMon, 03 Jun 2013 16:00:10 -0400Associated Pressadvice-black-women-breast-cancer-gene-risk-200010535<p><a href="http://news.yahoo.com/advice-black-women-breast-cancer-gene-risk-200010535.html"><img src="http://l3.yimg.com/bt/api/res/1.2/IQXuyMvaKWQAC.5ySpGJZQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3B4b2ZmPTUwO3B5b2ZmPTA7cT04NTt3PTEzMA--/http://media.zenfs.com/en_us/News/ap_webfeeds/f5549e7f992eb412330f6a7067008a0f.jpg" width="130" height="86" alt="In this May 31, 2013, photo, breast cancer survivor Alicia Cook holds a letter from the University of Chicago informing her that test results showed she had the BRCA genetic defect linked to breast cancer, outside her home in Chicago. New research shows genetic breast cancer is more common in black women than previously thought. (AP Photo/M. Spencer Green)" align="left" title="In this May 31, 2013, photo, breast cancer survivor Alicia Cook holds a letter from the University of Chicago informing her that test results showed she had the BRCA genetic defect linked to breast cancer, outside her home in Chicago. New research shows genetic breast cancer is more common in black women than previously thought. (AP Photo/M. Spencer Green)" border="0" /></a>CHICAGO (AP) ? New research suggests that bad genes may be responsible for more breast cancer cases in black women than has been previously known. About 1 in 5 African-American women with the disease have an inherited mutation that drastically raises their risk for breast and ovarian cancer, according to a study released Monday.</p><br clear="all"/>Pluristem Therapeutics Inc. said Tuesday the Food and Drug Administration suspended a clinical trial of one of its stem cell therapies, sending the company's shares lower. Pluristem said one patient in ...http://news.yahoo.com/pluristem-slumps-fda-suspends-stem-164125737.htmlTue, 04 Jun 2013 12:41:25 -0400Associated Presspluristem-slumps-fda-suspends-stem-164125737By Julie Steenhuysen CHICAGO (Reuters) - Researchers have been working for years to determine whether genetic glitches are driving high rates of especially deadly breast cancer in black women in the United States. Now, the most comprehensive genetic study yet found that one in five black women already diagnosed with breast cancer and referred for genetic counseling had at least one of 18 genetic mutations known to increase the risk of the disease. ...http://news.yahoo.com/study-finds-strong-genetic-links-blacks-breast-cancer-173352931.htmlMon, 03 Jun 2013 13:33:52 -0400Reutersstudy-finds-strong-genetic-links-blacks-breast-cancer-173352931WASHINGTON (Reuters) - The U.S. Agriculture Department must work with other agencies to ensure that the discovery of unapproved genetically engineered wheat in Oregon does not become an unfair barrier to trade, one of the state's U.S. Senators said on Friday. "The discovery of non-harvested, GE (genetically engineered) wheat should not be used by America's trading partners to erect spurious, protectionist trade barriers ... in the absence of scientific evidence indicating that Oregon exports contain this strain of wheat," Sen. Roy Wyden, a Democrat, wrote to USDA Secretary Tom Vilsack. ...http://news.yahoo.com/sen-wyden-warns-gene-altered-wheat-could-become-183553663.htmlFri, 31 May 2013 14:35:53 -0400Reuterssen-wyden-warns-gene-altered-wheat-could-become-183553663By Deena Beasley (Reuters) - Biotech stocks are so hot that even some of the bulls are starting to find themselves on edge. An index of biotech drugmakers' shares has climbed nearly 50 percent in the past 12 months to all-time highs as the industry starts to launch drugs developed by identifying genes associated with disease - a revolution made possible by decoding the first human genome more than 10 years ago. ...http://news.yahoo.com/analysis-biotechs-bull-run-starts-look-frothy-110206899.htmlTue, 28 May 2013 08:16:04 -0400Reutersanalysis-biotechs-bull-run-starts-look-frothy-110206899<p><a href="http://news.yahoo.com/swiss-billionaires-buy-merck-serono-hq-biotech-campus-134304063.html"><img src="http://l.yimg.com/bt/api/res/1.2/FrXw20KFGATsLbiJxltefg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-05-22T134917Z_1_CBRE94L12ED00_RTROPTP_2_MERCK-SERONO.JPG" width="130" height="86" alt="The new logo of bio pharmaceutical company Merck Serono SA is pictured outside the new headquarters in Geneva" align="left" title="The new logo of bio pharmaceutical company Merck Serono SA is pictured outside the new headquarters in Geneva" border="0" /></a>By Caroline Copley ZURICH (Reuters) - Swiss billionaire Ernesto Bertarelli has bought back the Geneva headquarters of his former biotech firm Serono, hoping to establish a biotech research campus. After selling the family business to German drugmaker Merck KGaA for $13.3 billion in 2006, the Harvard Business School graduate went on to win the America&#039;s Cup sailing prize for the second time. He and his former beauty queen wife Kirsty cut a high profile among the Swiss jet-set. ...</p><br clear="all"/>http://news.yahoo.com/swiss-billionaires-buy-merck-serono-hq-biotech-campus-134304063.htmlWed, 22 May 2013 09:43:04 -0400Reutersswiss-billionaires-buy-merck-serono-hq-biotech-campus-134304063<p><a href="http://news.yahoo.com/swiss-billionaires-buy-merck-serono-hq-biotech-campus-134304063.html"><img src="http://l.yimg.com/bt/api/res/1.2/FrXw20KFGATsLbiJxltefg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-05-22T134917Z_1_CBRE94L12ED00_RTROPTP_2_MERCK-SERONO.JPG" width="130" height="86" alt="The new logo of bio pharmaceutical company Merck Serono SA is pictured outside the new headquarters in Geneva" align="left" title="The new logo of bio pharmaceutical company Merck Serono SA is pictured outside the new headquarters in Geneva" border="0" /></a>By Caroline Copley ZURICH (Reuters) - Swiss billionaire Ernesto Bertarelli has bought back the Geneva headquarters of his former biotech firm Serono, hoping to establish a biotech research campus. After selling the family business to German drugmaker Merck KGaA for $13.3 billion in 2006, the Harvard Business School graduate went on to win the America&#039;s Cup sailing prize for the second time. He and his former beauty queen wife Kirsty cut a high profile among the Swiss jet-set. ...</p><br clear="all"/><p><a href="http://news.yahoo.com/uk-tries-model-gene-testing-cancer-patients-143135493.html"><img src="http://l2.yimg.com/bt/api/res/1.2/c_ur3lU4G9PxzZxkvSDH2g--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-05-20T143135Z_1_CBRE94J14CR00_RTROPTP_2_SCIENCE-NANOMEDICINE.JPG" width="130" height="86" alt="A tray containing cancer cells sits on an optical microscope in the Nanomedicine Lab at UCL&#039;s School of Pharmacy in London" align="left" title="A tray containing cancer cells sits on an optical microscope in the Nanomedicine Lab at UCL&#039;s School of Pharmacy in London" border="0" /></a>By Kate Kelland LONDON (Reuters) - Britain launched a research program on Monday that should eventually allow all cancer patients to have access to the kind of genetic analysis that led Hollywood star Angelina Jolie to decide to undergo a double mastectomy. The project, involving the Institute of Cancer Research (ICR) in London, the U.S. gene sequencing firm Illumina, geneticists and cancer doctors, aims to find a way to allow more cancer genes be tested in more people. Researchers announcing the 2. ...</p><br clear="all"/>http://news.yahoo.com/uk-tries-model-gene-testing-cancer-patients-143135493.htmlMon, 20 May 2013 10:31:35 -0400Reutersuk-tries-model-gene-testing-cancer-patients-143135493<p><a href="http://news.yahoo.com/uk-tries-model-gene-testing-cancer-patients-143135493.html"><img src="http://l2.yimg.com/bt/api/res/1.2/c_ur3lU4G9PxzZxkvSDH2g--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-05-20T143135Z_1_CBRE94J14CR00_RTROPTP_2_SCIENCE-NANOMEDICINE.JPG" width="130" height="86" alt="A tray containing cancer cells sits on an optical microscope in the Nanomedicine Lab at UCL&#039;s School of Pharmacy in London" align="left" title="A tray containing cancer cells sits on an optical microscope in the Nanomedicine Lab at UCL&#039;s School of Pharmacy in London" border="0" /></a>By Kate Kelland LONDON (Reuters) - Britain launched a research program on Monday that should eventually allow all cancer patients to have access to the kind of genetic analysis that led Hollywood star Angelina Jolie to decide to undergo a double mastectomy. The project, involving the Institute of Cancer Research (ICR) in London, the U.S. gene sequencing firm Illumina, geneticists and cancer doctors, aims to find a way to allow more cancer genes be tested in more people. Researchers announcing the 2. ...</p><br clear="all"/>Affymetrix Chief Financial Officer Tim Barabe is planning to retire from his post next month. The genetic testing instrument business said Monday that it is promoting Gavin Wood to the position. Barabe's ...http://news.yahoo.com/affymetrix-cfo-barabe-retire-june-102937943.htmlMon, 20 May 2013 06:29:37 -0400Associated Pressaffymetrix-cfo-barabe-retire-june-102937943

Source: http://rss.news.yahoo.com/rss/biotech

joan crawford john goodman kendall marshall whitney houston news sylvia plath whitney houston autopsy results obama trayvon